---
title: "BFRIW.US (BFRIW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BFRIW.US/news.md"
symbol: "BFRIW.US"
name: "BFRIW.US"
parent: "https://longbridge.com/en/quote/BFRIW.US.md"
datetime: "2026-03-08T08:15:16.244Z"
locales:
  - [en](https://longbridge.com/en/quote/BFRIW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BFRIW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BFRIW.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BFRIW.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BFRIW.US/news.md)


# BFRIW.US (BFRIW.US) — Related News

### ["Science" + "Cell" combine forces! Chen Yun and Li Wei/Zhou Qi et al. develop new cellular and molecular weapons for AD treatment: CAR-A astrocyte therapy and SPYTACs protein degradation technology](https://longbridge.com/en/news/278246147.md)
*2026-03-08T03:50:44.000Z*
> "Science" and "Cell" published new research on the treatment of Alzheimer's disease (AD). Chen Yun and others from the U

### [Nature: Back-to-back! Bacteria's "universal transcription key" - Chang Leifu and others discovered that the natural CRISPR system transforms into a gene activator, capable of activating gene expression according to RNA instructions](https://longbridge.com/en/news/278241401.md)
*2026-03-08T02:20:24.000Z*
> Purdue University's Chang Leifu and Columbia University's Samuel H. Sternberg collaborated to publish research in Nature

### [Manufacturing Industry Daily (03.07): Frontiers of Technological Breakthroughs](https://longbridge.com/en/news/278231001.md)
*2026-03-07T19:34:16.000Z*
> Taalas completed a financing of $169 million and launched its first AI chip HC1, aimed at addressing the computing power

### [FDA Accepts Biofrontera sNDA Filing for Ameluz PDT in Superficial Basal Cell Carcinoma](https://longbridge.com/en/news/275619475.md)
*2026-02-11T14:15:18.000Z*
> Biofrontera Inc. announced that the FDA has accepted its supplemental New Drug Application for Ameluz® in combination wi

### [BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 6.988 M](https://longbridge.com/en/news/265742238.md)
*2025-11-13T13:33:14.000Z*
### [BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 9.03 M](https://longbridge.com/en/news/252922280.md)
*2025-08-13T21:23:08.000Z*
### [BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 10-Q: FY2025 Q2 Revenue: USD 9.03 M](https://longbridge.com/en/news/252915142.md)
*2025-08-13T20:19:02.000Z*
### [BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 8-K: FY2025 Q1 Revenue: USD 8.588 M](https://longbridge.com/en/news/240453998.md)
*2025-05-15T21:12:07.000Z*
### [BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM) | 10-Q: FY2025 Q1 Revenue: USD 8.588 M](https://longbridge.com/en/news/240450945.md)
*2025-05-15T20:47:50.000Z*